Effects of peptide YY3-36 on PRL secretion: Pituitary and extra-pituitary actions in the rat

Peptides

Volumn 25, Issue 7, 2004, Pages 1147-1152

  Aguilar, E ^a   Fernandez Fernandez, R ^a   Tena Sempere, M ^a   Pinilla, L ^a  

^a UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

Ageing; NPY; Pituitary; PRL; Puberty; PYY3 36

Indexed keywords

PEPTIDE YY; PEPTIDE YY [3-36]; PROLACTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL RAT; EXPOSURE; FEMALE; HYPERPROLACTINEMIA; HYPOPHYSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PREPUBERTY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; PROTEIN FUNCTION; RAT; STATISTICAL SIGNIFICANCE;

AGING; ANIMALS; FEMALE; MALE; NEUROPEPTIDE Y; PEPTIDE YY; PITUITARY GLAND; PROLACTIN; RATS; RATS, WISTAR; SEXUAL MATURATION;

EID: 3042776486     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2004.04.002     Document Type: Article

References (43)

1. Baranowska B., Chmielowska M., Radzikowska M., Borowiec M., Roguski K., Wasilewska-Dziubinska E. Effects of neuropeptide Y (NPY) galanin and vasoactive intestinal peptide (VIP) on pituitary hormone release and on ovarian steroidogenesis. Neuroendocrinol. Lett. 20:1999;385-389
2. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 418:2002;650-654
3. Bauer-Dantoin A.C., McDonald J.K., Levine J.E. Neuropeptide Y potentiates luteinizing hormone (LH)-releasing hormone-stimulated LH surges in pentobarbital-blocked proestrous rats. Endocrinology. 129:1991;402-408
4. Bauer-Dantoin A.C., McDonald J.K., Levine J.E. Neuropeptide Y potentiates luteinizing hormone (LH)-releasing hormone-induced LH secretion only under conditions leading to preovulatory LH surges. Endocrinology. 131:1992;2946-2952
5. Crowley W.R., Kalra S. Neuropeptide Y stimulates the release of luteinizing hormone-releasing hormone from medial basal hypothalamus in vitro: modulation by ovarian hormones. Neuroendocrinology. 46:1987;97-103
6. 2+ influx through voltage-sensitive channels. Endocrinology. 127:1990;1487-1494
7. 2+ messenger systems together reverse dopaminergic inhibition of prolactin release. Endocrinology. 117:1985;439-446
8. Evans J.J. Modulation of gonadotropin levels by peptides acting at the anterior pituitary gland. Endocr. Rev. 20:1999;46-67
9. Freeman ME. The neuroendocrine control of the ovarian cycle of the rat. In: Knobil E, Neill JD, editors. The physiology of reproduction, vol. 2. New York: Raven Press, 1994. p. 613-58.
10. Garcia de Yebenes E., Li S., Fournier A., St-Pierre S., Pelletier G. Involvement of the Y2 receptor subtype in the regulation of prolactin gene expression by neuropeptide Y in the male rat. Neurosci. Lett. 190:1995;77-80
11. Garcia M.C., Lopez M., Gualillo O., Seoane L.M., Dieguez C., Senaris R.M. Hypothalamic levels of NPY, MCH, and prepro-orexin mRNA during pregnancy and lactation in the rat: role of prolactin. FASEB J. 17:2003;1392-1400
12. Ghosh P.K., Debeljuk L., Wagner T.E., Bartke A. Effect of immunoneutralization of neuropeptide Y on gonadotropin and prolactin secretion in normal mice and in transgenic mice bearing bovine growth hormone gene. Endocrinology. 129:1991;597-602
13. Gonzales C, Gaillard RC, Pedrazzini T, Pralong FP. The Y1 subtype of neuropeptide Y receptors mediates the inhibition of the activity of the gonadotrope axis induced by poor metabolic conditions. In: Proceedings of the Sixth European Congress of Endocrinology (O-58). Lyon, 2003.
14. Gore A.C., Mitsushima D., Terasawa E. A possible role of neuropeptide Y in the control of the onset puberty in female rhesus monkey. Neuroendocrinology. 58:1993;23-34
15. Harfstrand A., Eneroth P., Agnati L., Fuxe K. Further studies on the effects of central administration of neuropeptide Y on neuroendocrine function in the male rat: relationship to hypothalamic catecholamines. Regul. Pept. 17:1987;167-179
16. Ingram C.D., Bicknell R.J., Mason W.T. Intracellular recordings from bovine anterior pituitary cells: modulation of spontaneous activity by regulators of prolactin secretion. Endocrinology. 119:1986;2508-2518
17. Kalra S.P. Appetite and body weight regulation: is it all in the brain? Neuron. 19:1997;227-230
18. Kalra S.P., Dube M.G., Pu S., Xu B., Horvath T.L., Kalra P.S. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr. Rev. 20:1999;68-100
19. Keire D.A., Mannon P., Kobayashi M., Walsh J.H., Solomon T.E., Reeve J.R. Jr. Primary structures of PYY, [Pro(34)]PYY, and PYY-(3-36) confer different conformations and receptor selectivity. Am. J. Physiol. Gastrointest. Liver Physiol. 279:2000;G126-G131
20. Khorram O., Pau K.Y., Spies H.G. Release of hypothalamic neuropeptide Y and effects of exogenous NPY on the release of hypothalamic GnRH and pituitary gonadotropins in intact and ovariectomized does in vitro. Peptides. 9:1988;411-417
21. Koike K., Judd A.M., Login I.S., Yasumoto T., MacLeod R.M. Maitotoxin, a calcium channel activator, increases prolactin release from rat pituitary tumor 7315a cells by a mechanism that may involve leukotriene production. Neuroendocrinology. 43:1986;283-290
22. Larhammar D. Extraordinary structural diversity of NPY-family receptors. In: Grundemar L, Bloom SR, editors. Neuropeptide Y and drug level. San Diego: Academic Press, 1997. p. 87-105.
23. Leupen S.M., Levine J.E. Role of protein kinase C in facilitation of luteinizing hormone (LH)-releasing hormone-induced LH surges by neuropeptide Y. Endocrinology. 140:1998;3682-3687
24. McDonald J.K., Lumpkin M.D., Samson W.K., McCann S.M. Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats. Proc. Natl. Acad. Sci. USA. 82:1985;561-564
25. McDonald J.K., Koenig J.I., Gibbs D.M., Collins P., Noe B.D. High concentrations of neuropeptide Y in pituitary portal blood of rats. Neuroendocrinology. 46:1987;538-541
26. MohanKumar P.S., MohanKumar S.M., Quadri S.K., Voogt J.L. Responsiveness of tuberoinfundibular dopaminergic neurons to 5-hydroxytryptophan: effects of aging. Endocrine. 9:1998;33-37
27. Parker M.S., Wang J.J., Fournier A., Parker S.L. Upregulation of pancreatic-polypeptide-sensitive neuropeptide Y (NPY) receptors in estrogen-induced hypertrophy of the anterior pituitary gland in the Fischer-344 rat. Mol. Cell. Endocrinol. 164:2000;239-249
28. Pinilla L., Gonzalez L., Tena-Sempere M., Aguilar E. Activation of AMPA receptors inhibits prolactin and estradiol secretion and delays the onset of puberty in female rats. J. Steroid Biochem. Mol. Biol. 75:2000;277-281
29. Pralong F.P., Voirol M., Giacomini M., Gaillard R.C., Grouzmann E. Acceleration of pubertal development following central blockade of the Y1 subtype of neuropeptide Y receptors. Regul. Pept. 95:2000;47-52
30. Raposinho P.D., Pierroz D.D., Broqua P., White R.B., Pedrazzini T., Aubert M.L. Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism. Mol. Cell. Endocrinol. 185:2001;195-204
31. Russell S.H., Small C.J., Kennedy A.R., Stanley S.A., Seth A., Murphy K.G., et al. Orexin A interactions in the hypothalamo-pituitary gonadal axis. Endocrinology. 142:2001;5294-5302
32. Sahu A., Kalra P.S., Kalra S.P. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y concentrations in the paraventricular nucleus. Peptides. 9:1988;83-86
33. Schettini G., Cronin M.J., MacLeod R.M. Adenosine 3′, 5′-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization. Endocrinology. 112:1983;1801-1807
34. Shangold G.A., Miller R.J. Direct neuropeptide Y-induced modulation of gonadotrope intracellular calcium transients and gonadotropin secretion. Endocrinology. 126:1990;2336-2342
35. Sheikh S.P., Feldthus N., Orkild H., Goke R., McGregor G.P., Turner D., et al. Neuropeptide Y2 receptors on nerve endings from the rat neurohypophysis regulate vasopressin and oxytocin release. Neuroscience. 82:1998;107-115
36. Sutton S.W., Toyama T.T., Otto S., Plotsky P.M. Evidence that neuropeptide Y (NPY) released into the hypophysial-portal circulation participates in priming gonadotropes to the effects of gonadotropin releasing hormone (GnRH). Endocrinology. 123:1988;1208-1210
37. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc. Natl. Acad. Sci. U.S.A. 79:1982;5485-5489
38. Tena-Sempere M., Barrerio M.L. Leptin in male reproduction: The testis paradigm. Mol. Cell. Endocrinol. 188:2002;9-13
39. Tena-Sempere M., Barreiro M.L., Gonzalez L.C., Gaytan F., Zhang F.P., Caminos J.E., et al. Novel expression and functional role of ghrelin in rat testis. Endocrinology. 143:2002;717-725
40. Thorner M.O., Hackett J.T., Murad F., MacLeod R.M. Calcium rather than cyclic AMP as the physiological intracellular regulator of prolactin release. Neuroendocrinology. 31:1980;390-402
41. Toufexis D.J., Kyriazis D., Woodside B. Chronic neuropeptide Y Y5 receptor stimulation suppresses reproduction in virgin female and lactating rats. J. Neuroendocrinol. 14:2002;492-497
42. Wang J., Ciofi P., Crowley W.R. Neuropeptide Y suppresses prolactin secretion from rat anterior pituitary cells: evidence for interactions with dopamine through inhibitory coupling to calcium entry. Endocrinology. 137:1996;587-594
43. Zhu J., Li W., Toews M.L., Hexum T.D. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process. J. Pharmacol. Exp. Ther. 263:1992;1479-1486